Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stapokibart in seasonal allergic rhinitis
NCT06300203Phase 2Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Mar 2024
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of stapokibart in seasonal allergic rhinitis (SAR), sponsored by Beijing Tongren Hospital. Started Mar 2024; status: recruiting.
02
Drugs
stapokibart
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT06300203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06300203.